tiprankstipranks
LAVA Therapeutics (LVTX)
NASDAQ:LVTX
US Market

LAVA Therapeutics (LVTX) Income Statement

Compare
156 Followers

LAVA Therapeutics Income Statement

Last quarter (Q3 2024), LAVA Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, LAVA Therapeutics's net income was $-12.30M. See LAVA Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 6.77M$ 19.39M$ 5.35M$ 3.75M$ 0.00
Gross Profit
$ 3.29M$ 19.39M$ 5.35M$ -11.95M$ -8.35M
Operating Expenses
$ 46.54M$ 51.31M$ 46.92M$ 3.59M$ 1.25M
Depreciation and Amortization
$ 1.28M$ 504.00K$ 331.00K$ 213.00K$ 99.00K
EBITDA
$ -40.42M$ -30.88M$ -41.02M$ -14.65M$ -9.48M
Operating Income
$ -43.25M$ -34.84M$ -43.61M$ -14.67M$ -9.58M
Other Income/Expenses
$ 1.56M$ 3.18M$ 1.42M$ -1.21M$ -104.00K
Pretax Income
$ -41.70M$ -31.66M$ -42.20M$ -15.88M$ -9.69M
Net Income
$ -41.97M$ -31.91M$ -42.35M$ -15.93M$ -9.69M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.57$ -1.23$ -2.14$ -39.90$ -21.65
Diluted EPS
$ -1.57$ -1.23$ -2.14$ -39.90$ -21.65
Weighted Average Shares Outstanding
26.73M 25.92M 19.76M 25.35M 18.41M
Weighted Average Shares Outstanding (Diluted)
26.73M 25.92M 19.76M 25.35M 18.41M
Currency in USD

LAVA Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis